AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Evercore, you have to believe in the durability of its advisory franchise and its ability to convert that into disciplined capital returns, rather than chasing balance sheet risk. The latest quarter’s record US$1.30 billion in revenue and US$203.95 million in net income, combined with another US$0.84 dividend and completion of a US$251.79 million buyback, reinforces that story rather than changing it. Near term, the key catalyst remains deal activity across M&A, restructuring and capital advisory, and the firm’s willingness to keep investing in senior talent. The hiring of Jonathan Dale in London fits that theme by deepening its EMEA consumer bench, but it does not remove the core risks: a cyclical deal environment, a richer-than-peer valuation and the need to justify sustained high returns on equity.
However, investors should also weigh how a premium valuation can amplify those cycle risks. Evercore's shares have been on the rise but are still potentially undervalued by 38%. Find out what it's worth.Three Simply Wall St Community fair values for Evercore span roughly US$353.56 to a very large US$577.34, underscoring how far apart individual views can be. Set against a premium earnings multiple and heavy reliance on deal volumes, that spread highlights why it is worth comparing several perspectives before deciding how much of your portfolio, if any, you want exposed to this kind of earnings cyclicality.
Explore 3 other fair value estimates on Evercore - why the stock might be worth just $353.56!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com